Suchergebnisse - "Moser, Stephan"

PubPharm (7)

1

Recombinant C1 inhibitor in the prevention of severe COVID-19 : a randomized, open-label, multi-center phase IIa trial

enthalten in: Frontiers in immunology | 2023

von Urwyler, P. | Leimbacher, M. | Charitos, P. | +12

2

Targeting thromboinflammation in COVID-19 - A narrative review of the potential of C1 inhibitor to prevent disease progression

enthalten in: Molecular immunology | 2022

von Urwyler, P. | Moser, S. | Trendelenburg, M. | +2

3

Complement and endothelial cell activation in COVID-19 patients compared to controls with suspected SARS-CoV-2 infection : A prospective cohort study

enthalten in: Frontiers in immunology | 2022

von Bruni, F. | Charitos, P. | Lampart, M. | +9

4

Probability of pharmacological target attainment with flucloxacillin in Staphylococcus aureus bloodstream infection : a prospective cohort study of unbound plasma and individual MICs

enthalten in: The Journal of antimicrobial chemotherapy | 2021

von Moser, S. | Rehm, S. | Guertler, N. | +6

5

A Randomized Trial of Recombinant Human C1-Esterase-Inhibitor in the Prevention of Contrast-Induced Kidney Injury

enthalten in: JACC. Cardiovascular interventions | 2020

von Panagiotou, A. | Trendelenburg, M. | Heijnen, I. | +7

CommentIn: JACC Cardiovasc Interv. 2020 Apr 13;13(7):843-845. - PMID 32171716

6

Recovery from possible late-onset Alzheimer's dementia? Evidence from a longitudinal community-based age-cohort study

enthalten in: Journal of the American Geriatrics Society | 2013

von Kudrnovsky-Moser, S. | Jungwirth, S. | Zehetmayer, S. | +3

7

Transplacental traffic after in utero mesenchymal stem cell transplantation

enthalten in: Stem cells and development | 2010

von Troeger, C. | Perahud, I. | Moser, S. | +1

1
[1]